Rays of Belief Limited, incorporated in 2017 and launching commercial operations in 2018 under the clinical brand name Mom’s Belief, is a pioneering multi-channel early intervention and therapeutic care platform. The company operates as a For-Profit Social Enterprise. Its core value proposition is designed to address the major barriers in the neurodevelopmental care sector—specifically, a chronic lack of public awareness, late childhood diagnosis, a shortage of trained clinical specialists, and high therapy costs. Through its integrated clinical network, the company provides personalized intervention and therapy plans for children diagnosed with neurodevelopmental disorders (NDDs). This is delivered via a parent-empowered clinical model where clinical professionals train parents and caregivers to act as co-therapists, ensuring structured therapy continues in the home environment.
The company's primary client segments are pediatric and infant populations, serving children from early development up to 15 years of age. These demographics are divided into four distinct age-targeted service verticals: early infant screening and developmental support (infancy to 2 years), play-based school-readiness programs (3 to 5 years), academic and social behavior therapies (6 to 12 years), and vocational or life-skills transitional programs for older adolescents (13 to 15 years). Each child enrolled in Mom’s Belief undergoes a multi-disciplinary baseline assessment, after which the clinical team drafts a highly customized Individualized Education Plan (IEP) and Individualized Goal Plan (IGP) tailored to their specific needs. Till date, the company has achieved a cumulative service outreach of upwards of 58,000 children since its inception.
Rays of Belief Limited delivers these services through an asset-light, multi-tiered network of centers. The network is structured around Company Learning Centres (CLCs), which are wholly leased, established, and managed directly by the company; Company Learning Centres in Partnership with Licensed Professionals, operated jointly inside the clinics of pediatricians, child psychiatrists, and allied therapists with a shared financial model; and School Collaboration Centres, which are clinical therapy units established within partner schools to support neurodivergent students in mainstream environments. This network scaled from 71 centers in Fiscal 2023 to 139 operational centers as of March 31, 2026, creating India’s largest clinical care footprint in this specialized healthcare niche.
The geographic reach of the company covers 57 cities spanning 20 states and union territories across India, with a strategic focus on Tier-2 and Tier-3 urban locations to serve semi-urban communities that have historically lacked access to developmental pediatricians. Out of the 139 centers, 42 are located in Tier-1 cities, 77 in Tier-2 cities, and 17 in Tier-3 cities. Furthermore, on June 23, 2025, the company expanded its international footprint through the acquisition of its wholly owned U.S. subsidiary, Mom's Belief US Inc., and its step-down subsidiary, Allergy & Immunology Virginia, LLC. This acquisition added 3 overseas centers located in Salem, Lynchburg, and Roanoke, Virginia, enabling the group to tap into high-margin U.S. commercial insurance payor systems.
The group's operational infrastructure is backed by a robust physical and digital tool library. Its clinical centers are equipped with over 150 specialized teaching tools, including sensory integration equipment, cognitive puzzles, and worksheets. For home-based intervention, the company has developed and manufactures over 2,000 customized, play-based therapeutic and educational home-learning kits (such as developmental LEGO-integrated kits). These kits are delivered directly to the clients' homes and are supported by cloud-based digital trackers and Whatsapp communication channels so clinical professionals can monitor a child’s progress in real-time.
Because Rays of Belief Limited is a specialized healthcare service and clinical therapy provider, traditional manufacturing plants, factory locations, and industrial capacity utilization metrics are Not Applicable / Not Disclosed in Document.Instead, the company’s operational moat lies in its internal R&D capabilities, driven by a clinical workforce of over 340 full-time clinical professionals. The central R&D team designs clinical plans based on evidence-based global standards, incorporating research-validated methodologies such as the Preschool Autism Communication Trial (PACT) and Joint Attention, Symbolic Play, Engagement, and Regulation (JASPER). Standardized care is maintained across the distributed network via central clinical oversight, random session audits, and structured weekly parent feedback loops.
As per financial performance, Rays of Belief Limited has posted total income / net profits of Rs 30.76 Cr / Rs 0.85 Cr (FY24), Rs 36.54 Cr / Rs 5.88 Cr (FY25) and Rs 82.06 Cr / Rs 4.96 Cr (FY26). So as per previous financials data, the company has shown steady top-line expansion with a revenue CAGR of 63.34% and strong operating leverage as pre-tax profits rose from Rs 0.10 Cr in FY24 to Rs 6.90 Cr in FY26, alongside a deleveraging trend where total outstanding debt decreased from Rs 4.36 Cr in FY25 to Rs 3.61 Cr in FY26. Company has an average EPS of Rs 2.98 and average RoNW of 32.48% for the last three fiscals. Based on the pre-issue book value, the issue is priced at a Pre-Issue P/BV of 15.25x as per NAV of Rs 15.67 as on 31.03.26. Factoring in the fresh issue proceeds, the Post-Issue P/BV stands at 3.21x (on a consolidated net worth basis of Rs 74.54 per share). If we attribute the latest earnings of FY24, FY25, and FY26 to the expanded equity base post-issue, then the asking price is at a Post-Issue P/E of around 585.64x, 84.94x, and 100.74x respectively. As per RHP, a comparison between listed peers shows that there are no listed domestic or international companies whose business scale and neurodevelopmental portfolio are directly comparable, rendering direct peer valuation benchmarks not applicable.
On BRLM's front, Mefcom Capital Markets Limited is associated with this IPO4849, and the sole Book Running Lead Manager (Mefcom Capital Markets Limited) has handled 1 IPO (Globe Civil Projects Limited) in the last three fiscal years. (As On 24.08.26)
✍️ Post a Comment